News Releases

OptimizeRx to Participate in Upcoming Investor Conferences

November 18, 2024 at 7:30 AM EST

WALTHAM, Mass., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences:

13^th Annual ROTH Technology Conference, New York City, November 19^th – 20^th, 2024
Canaccord Genuity’s 2024 CG MedTech, Diagnostics and Digital Health & Services Forum, New York City, November 21^st, 2024

Conference Details:

13^th Annual ROTH Technology Conference
Date:	Tuesday, November 19^t^h – Wednesday 20^th
Format:	1x1 Meetings
Location:	The Hard Rock Hotel, New York City
Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
Date:	Thursday, November 21^s^t
Format:	1x1 Meetings
Location:	The Westin NY Grand Central, New York City

To request a meeting or for more details about the conferences please reach out to your institutional contact or email.

About OptimizeRx
OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 2 million U.S. healthcare providers and millions of their patients through an intelligent technology platform embedded within a proprietary digital point-of-care network, as well as mass digital communication channels, OptimizeRx helps life sciences organizations engage and support their customers.

For more information, follow the Company on X, LinkedIn or visit www.optimizerx.com. 

OptimizeRx Contact
Andy D’Silva, SVP Corporate Finance
adsilva@optimizerx.com

Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC
arr@lifesciadvisors.com

Source: OptimizeRx Corporation